Combining an IMPDH2 inhibitor with an ATR kinase inhibitor caused synergistic replication stress in vitro and suppressed MCC tumor growth in vivo, suggesting a therapeutic strategy to exploit replication stress in MCC [26]. Here, IMPDH2 is linked to Merkel cell skin cancer.